BANK OF AMERICA CORP /DE/ - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 106 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$617,355
+41.5%
139,044
+5.1%
0.00%
Q2 2023$436,385
+261.4%
132,238
+212.1%
0.00%
Q1 2023$120,754
-71.2%
42,370
-26.5%
0.00%
Q4 2022$419,567
+73.4%
57,633
+93.3%
0.00%
Q3 2022$242,000
-52.4%
29,818
-71.2%
0.00%
Q2 2022$508,000
+44.7%
103,667
+599.0%
0.00%
Q1 2022$351,000
-29.1%
14,831
-47.0%
0.00%
Q4 2021$495,000
+134.6%
27,964
+274.5%
0.00%
Q3 2021$211,000
+95.4%
7,468
-27.3%
0.00%
Q2 2021$108,000
+83.1%
10,277
+105.3%
0.00%
Q1 2021$59,000
-70.4%
5,005
-70.5%
0.00%
Q4 2020$199,000
+586.2%
16,972
+362.8%
0.00%
Q3 2020$29,000
-90.3%
3,667
-77.5%
0.00%
Q2 2020$298,000
+60.2%
16,332
+5.3%
0.00%
Q1 2020$186,000
+500.0%
15,514
+739.0%
0.00%
Q4 2019$31,000
+40.9%
1,849
-41.7%
0.00%
Q3 2019$22,0003,1700.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$19,415,0007.94%
TRV GP IV, LLC 2,343,154$11,481,0007.55%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 949$193,741,0002.02%
Logos Global Management LP 1,950,000$9,555,0001.75%
COWEN AND COMPANY, LLC 2,385,885$11,691,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,355,624$16,443,0000.62%
ACUTA CAPITAL PARTNERS, LLC 200,000$980,0000.55%
RTW INVESTMENTS, LP 3,961,194$19,410,0000.50%
Parkman Healthcare Partners LLC 262,689$1,287,0000.47%
Deep Track Capital, LP 1,000,000$4,900,0000.32%
View complete list of FULCRUM THERAPEUTICS INC shareholders